526345 Stock Overview
Manufactures and trades in consumer and pharmaceutical products in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Panjon Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹22.70 |
| 52 Week High | ₹24.99 |
| 52 Week Low | ₹14.28 |
| Beta | 0.16 |
| 11 Month Change | 20.68% |
| 3 Month Change | 3.99% |
| 1 Year Change | 51.03% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 138.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| 526345 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 3.2% | -0.6% | 0.8% |
| 1Y | 51.0% | 51.3% | 36.2% |
Return vs Industry: 526345 matched the Indian Pharmaceuticals industry which returned 51.3% over the past year.
Return vs Market: 526345 exceeded the Indian Market which returned 36.2% over the past year.
Price Volatility
| 526345 volatility | |
|---|---|
| 526345 Average Weekly Movement | 6.1% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.3% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 526345 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 526345's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1964 | 5 | Jay Kothari | www.panjon.in |
Panjon Limited manufactures and trades in consumer and pharmaceutical products in India. It operates through Manufacturing and Trading segments. The company offers tablets, balms, cough syrups and drops, inhalers, hair oil, cough drops, digestive candies and drops, energy drink, dental care creams, and mouth freshner, as well as awla, khajoor, chatpati, and shoppee.
Panjon Limited Fundamentals Summary
| 526345 fundamental statistics | |
|---|---|
| Market cap | ₹463.81m |
| Earnings (TTM) | ₹1.67m |
| Revenue (TTM) | ₹134.05m |
268.8x
P/E Ratio3.3x
P/S RatioIs 526345 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 526345 income statement (TTM) | |
|---|---|
| Revenue | ₹134.05m |
| Cost of Revenue | ₹103.86m |
| Gross Profit | ₹30.19m |
| Other Expenses | ₹28.52m |
| Earnings | ₹1.67m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 14, 2024
| Earnings per share (EPS) | 0.084 |
| Gross Margin | 22.52% |
| Net Profit Margin | 1.24% |
| Debt/Equity Ratio | 9.7% |
How did 526345 perform over the long term?
See historical performance and comparison